T50 - the new treatment target for patients with chronic kidney disease

 

Board of directors 



PD Dr. Andreas Pasch, President

is a Swiss board certified (FMH) practicing Nephrologist and Internist. He studied medicine at the University of Tübingen (D). He spent fifteen years of clinical work at Bruderholzspital Basel and University Hospital (Inselspital) Bern, both Switzerland.  As part of his medical research (clinical, pre-clinical, basic science) he invented the T50 test, based on an urgent clinical need. 



Phil. nat. Vincent Linder, member

is a serial entrepreneur and senior advisor, with experience developing IVD product from invention to regulatory approvals (FDA and CE-marks). 


Peter Steinmann, member

MBA & BA-Economics.  Key experience: general management, finance, business development, stakeholder management & communication. Active board member of startups as well as listed MedTech companies. Former President of Ethicon-Endo Surgery (J&J) Europe and Corporate Vice President Medtronic Europe.


Karsten Uhlmann, member

Chemical engineer, managing owner of an international brewing group. Senior entrepreneur with extensive business experience in various fields.


Dr. Sc. Pierre Comte, Business Advisor, Innosuisse accredited coach

has coached multiple biotech and medical device startup companies, including strategy building, fundraising, market entry and multiple successful exits. Former President Johnson & Johnson Professional Europe, Sulzermedica Orthopedics division and Director Straumann AG.